ArticleScientific reports2025
Effect of microbubble-assisted gemcitabine delivery with repeated ultrasound exposure in a pancreatic cancer organ-on-a-chip model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Focused ultrasound for cellular mechanoactivation and nanomedicine delivery in cancer.Biomedical microdevices · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The fibrotic stroma of solid tumours poses a physical barrier to drug delivery and effective treatment. Interaction between cancerous epithelial cells and their surrounding stromal partners results in the development of a rigid, collagenous matrix environment with reduced interstitial flow, crucial for drug delivery to cancer cells, particularly in pancreatic ductal adenocarcinoma (PDAC), an aggressive pancreatic cancer with poor prognosis. Therefore, evaluating novel drug delivery mechanisms using appropriate stroma-mimicking 3D culture models is essential. We previously demonstrated, using a 21-day cultured microfluidic PDAC model that mimics the rigid, collagenous stroma, reduced interstitial flow through the tumour model. In this study, we evaluated the use of microbubbles and ultrasound as an alternative method for disrupting our model's fibrotic stroma to restore interstitial flow and improve gemcitabine delivery and efficacy. Literature shows microbubbles in 2D and 3D static cultures enhance drug delivery and effects by increasing cell membrane permeability through oscillation and bursting under ultrasound (sonoporation). Here, we observed continuous microbubble oscillation and bursting under repeated ultrasound exposure, leading to continuous matrix-microbubble and PDAC cell-microbubble interactions, which improved the gemcitabine effect. This study emphasises the need for disease-specific in vitro models to assess novel drug delivery mechanisms and improve therapeutic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.